Here is how BellRing Brands (BRBR) and Aclaris Therapeutics (ACRS) have performed compared to their sector so far this year.
I give a buy rating for BellRing Brands due to expected mid-teens growth driven by increased supply, robust demand, and marketing initiatives. BRBR's revenue growth is supported by capacity expansion, distribution gains, and price increases, with a strong focus on the shakes and RTD category. Marketing investments are set to increase, which should help BRBR capture more demand.
The food industry is ripe for consolidation now that the Federal Reserve is expected to cut interest rates in September.
BellRing Brands reported its Q3 results beating Wall Street estimates, showing great growth momentum and incredibly strong gross margins from raw powder deflation. Despite the good overall report, rapid SG&A inflation is a concern as employee expenses and costs in warehousing and logistics are growing faster than revenues. The revised FY2024 guidance raises the bar for Q4, still expecting a sequential aEBITDA decline.
BellRing Brands (BRBR) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.34 per share a year ago.
BellRing Brands (BRBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BellRing Brands (BRBR) reachead $49.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
BellRing Brands (BRBR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
BellRing Brands (BRBR) closed at $56.87 in the latest trading session, marking a -0.84% move from the prior day.
The ingenuity shown by the most innovative companies means that the stock market keeps producing life-changing growth stocks every year. These young companies continue to become behemoths.
Here is how BellRing Brands (BRBR) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.